The aim is to build and strengthen a network of clinical trial units within the National Cancer Grid (NCG) to promote multicentric high-quality clinical trials for affordable therapy in oncology, which will enhance the capability for conduct of Industrysponsored trials of new cancer drugs and biosimilars by : Manpower training and infrastructure development, process harmonization between centres and to conduct collaborative investigator - initiated research. There are 11 sites (7 public and 4 private) in the consortia from different regions under PAN India. Tata Memorial Hospital, Mumbai is Lead site of the multicentric Clinical Trial Network (CTN). Prospective Registry database in Lymphomas, Chronic Myelogenous Leukemia, Colorectal Cancer, Lung Cancer, Gall Bladder Cancer is being created across sites of the network.
